JP2025511277A5 - - Google Patents
Info
- Publication number
- JP2025511277A5 JP2025511277A5 JP2024558235A JP2024558235A JP2025511277A5 JP 2025511277 A5 JP2025511277 A5 JP 2025511277A5 JP 2024558235 A JP2024558235 A JP 2024558235A JP 2024558235 A JP2024558235 A JP 2024558235A JP 2025511277 A5 JP2025511277 A5 JP 2025511277A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- pharmaceutically acceptable
- pharmaceutical composition
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263326773P | 2022-04-01 | 2022-04-01 | |
| US63/326,773 | 2022-04-01 | ||
| PCT/US2023/017348 WO2023192686A1 (en) | 2022-04-01 | 2023-04-03 | Methods for preventing or slowing the progression of cognitive decline or impairment in subjects displaying normal cognitive performance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511277A JP2025511277A (ja) | 2025-04-15 |
| JP2025511277A5 true JP2025511277A5 (https=) | 2026-04-17 |
Family
ID=88203560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558235A Pending JP2025511277A (ja) | 2022-04-01 | 2023-04-03 | 正常な認知能力を示す対象における認知低下もしくは認知障害の進行を予防する、または減速させるための方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250228820A1 (https=) |
| EP (1) | EP4504176A1 (https=) |
| JP (1) | JP2025511277A (https=) |
| CN (1) | CN119730849A (https=) |
| AU (1) | AU2023243233A1 (https=) |
| CA (1) | CA3255777A1 (https=) |
| IL (1) | IL316051A (https=) |
| MX (1) | MX2024012122A (https=) |
| WO (1) | WO2023192686A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120584115A (zh) * | 2022-08-19 | 2025-09-02 | 艾吉因生物股份有限公司 | 苯并氮杂䓬衍生物、组合物和用于治疗认知损害的方法 |
| WO2025148578A1 (zh) * | 2024-01-09 | 2025-07-17 | 浙江同源康医药股份有限公司 | 布立西坦口腔溶膜速释制剂组合物及其制剂和用途 |
| CN118518805B (zh) * | 2024-07-25 | 2024-09-24 | 成都诺和晟泰生物科技有限公司 | 一种左乙拉西坦口服溶液中右乙拉西坦的检测方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014144663A1 (en) * | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| WO2016191288A1 (en) * | 2015-05-22 | 2016-12-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
| MA50634A (fr) * | 2015-05-22 | 2021-04-28 | Agenebio Inc | Compositions pharmaceutiques à libération prolongée comportant du lévétiracétam |
| CN116075302A (zh) * | 2020-07-10 | 2023-05-05 | 艾吉因生物股份有限公司 | GABAAα5激动剂和SV2A抑制剂的组合以及在认知损害的治疗中的使用方法 |
-
2023
- 2023-04-03 EP EP23781936.2A patent/EP4504176A1/en active Pending
- 2023-04-03 IL IL316051A patent/IL316051A/en unknown
- 2023-04-03 CA CA3255777A patent/CA3255777A1/en active Pending
- 2023-04-03 CN CN202380042245.8A patent/CN119730849A/zh active Pending
- 2023-04-03 AU AU2023243233A patent/AU2023243233A1/en active Pending
- 2023-04-03 WO PCT/US2023/017348 patent/WO2023192686A1/en not_active Ceased
- 2023-04-03 JP JP2024558235A patent/JP2025511277A/ja active Pending
- 2023-04-03 US US18/852,724 patent/US20250228820A1/en active Pending
-
2024
- 2024-09-30 MX MX2024012122A patent/MX2024012122A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025511277A5 (https=) | ||
| JP7108146B2 (ja) | 新規メチルキナゾリノン誘導体 | |
| JP6505013B2 (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| TWI851536B (zh) | 治療克羅恩氏病和潰瘍性結腸炎之方法 | |
| JP2021191798A (ja) | Ｈｉｖカプシド阻害剤の固体形態 | |
| CA3255777A1 (en) | METHODS FOR PREVENTING OR SLOWING DOWN THE PROGRESSION OF COGNITIVE DECLINE OR DISORDER IN SUBJECTS WITH NORMAL COGNITIVE PERFORMANCE | |
| JP2023062189A (ja) | 癌を処置する方法 | |
| JP2021531256A (ja) | ＮａＶ１．８を阻害するピリダジン化合物 | |
| US20240285596A1 (en) | Solid dosage forms and dosing regimens comprising (2r,3s,4s,5r)-4-[[3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl) tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide | |
| JP2024534804A5 (https=) | ||
| AU2018379992B2 (en) | Nonracemic mixtures and uses thereof | |
| AU2016219906A1 (en) | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof | |
| KR20190117790A (ko) | 베타-락타마제 억제제를 포함하는 고체 형태 및 조합 조성물과 이의 용도 | |
| JP2017500334A5 (https=) | ||
| JP2013537194A5 (ja) | 疾患を治療するための医薬品及び同医薬品を含むキット | |
| JP2013542267A5 (https=) | ||
| JP2021530525A (ja) | ループス腎炎を処置するための特定の（２ｓ）−ｎ−［（１ｓ）−１−シアノ−２−フェニルエチル］−１，４−オキサゼパン−２−カルボキサミド | |
| JP2023534189A5 (https=) | ||
| JP2019528303A (ja) | 神経原性起立性低血圧の処置に使用するための化合物 | |
| IL299754A (en) | Combinations of gaba alpha 5 agonists and sv2a inhibitors and methods of using in the treatment of cognitive impairment | |
| JP2020509043A5 (https=) | ||
| CN114007689A (zh) | 心肌肌钙蛋白活化剂的多晶型物和共晶体 | |
| JP7569953B2 (ja) | Ｓｓｔｒ４アゴニスト及びその塩の調製のための方法並びに使用のための用量レジメン | |
| CN114349745B (zh) | 一种用于治疗心肌缺血的药物及其制备方法 | |
| WO2016206576A1 (zh) | 一种氘代噻吩并哌啶衍生物、制备方法及其应用 |